Linagliptin CAS 668270-12-0 Purity ≥99.0% (HPLC) Factory

Kufotokozera Kwachidule:

Dzina la mankhwala: Linagliptin

CAS: 668270-12-0

Kuyera: ≥99.0% (HPLC)

Maonekedwe: Ufa Woyera Kapena Woyera Wamakristalo

Linagliptin pochiza matenda amtundu wa 2 shuga mellitus

API, High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Titumizireni imelo

Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Wopanga Zinthu, Kuyera Kwambiri, Kupanga Zamalonda
Dzina la mankhwala: Linagliptin
CAS: 668270-12-0

Chemical Properties:

Dzina la Chemical	Linagliptin
Mawu ofanana ndi mawu	BI-1356;8--[(3R)-3-Amino-1-piperidinyl]-7-(2-butnyl)-3,7-dihydro-3-methyl-1--[(4-methyl-2-quinazolinyl)methyl]-1H -purine-2,6-dione
Nambala ya CAS	668270-12-0
Nambala ya CAT	RF-API105
Stock Status	Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula	C25H28N8O2
Kulemera kwa Maselo	472.54
Melting Point	197.0 mpaka 200.0 ℃
Kusungunuka	Zosungunuka mu DMSO
Mtundu	Ruifu Chemical

Zofotokozera:

Kanthu	Zofotokozera
Maonekedwe	Ufa Woyera kapena Woyera wa Crystalline
NMR	Zogwirizana ndi Kapangidwe
Kuyera / Kusanthula Njira	≥99.0% (HPLC)
Kutaya pa Kuyanika	≤0.50%
Zotsalira pa Ignition	≤0.10%
Zitsulo Zolemera	≤10ppm
Zogwirizana nazo
Chidetso Chimodzi	≤0.50%
Zonse Zonyansa	≤1.0%
Isomer	≤0.15%
Zosungunulira Zotsalira
Methanol	≤3000ppm
Isopropanol	≤5000ppm
DMF	≤800ppm
Dichloromethane	≤600ppm
Test Standard	Enterprise Standard
Kugwiritsa ntchito	API

Phukusi & Kusungira:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

FAQ:

Ntchito:

Linagliptin (CAS: 668270-12-0) ndi DPP-4 inhibitor yopangidwa ndi Boehringer Ingelheim pochiza matenda amtundu wachiwiri.Makhalidwe awiri azachipatala omwe amasiyanitsa linagliptin ndi zoletsa zina za DPP-4 ndikuti ili ndi mbiri ya pharmacokinetic yopanda mzere ndipo siyimachotsedwa kwenikweni ndi aimpso.Linagliptin (kamodzi patsiku) idavomerezedwa ndi US FDA pa Meyi 2, 2011 pochiza matenda a shuga amtundu wachiwiri.Ikugulitsidwa ndi Boehringer Ingelheim ndi Lilly.Linagliptin, wogulitsidwa pansi pa dzina la Tradjenta pakati pa ena.Amagwiritsidwa ntchito limodzi ndi masewera olimbitsa thupi komanso zakudya.